Coastlands Capital LP 4

What Happened
Coastlands Capital LP, reported as a 10% owner of ADIAL Pharmaceuticals, purchased 25,000 shares of ADIL common stock on 2026-06-29 at $2.60 per share, for a total purchase price of $65,000. The Form 4 lists the transaction as an open market or private purchase (transaction code P). This was a purchase (acquisition), which investors often view as a more informative signal than routine sales.

Key Details

• Transaction date and price: 2026-06-29 — 25,000 shares at $2.60 each.
• Total value: $65,000.
• Filing date: Form 4 filed 2026-07-01 (covers the 06-29 transaction); filing appears timely (Form 4 is generally due within two business days).
• Shares owned after transaction: not specified/disclosed in the provided filing.
• Footnote summary (F1): Coastlands Capital LP, Coastlands Capital GP LLC, Coastlands Capital LLC and related entities are part of the reporting group; Matthew Perry is identified as the control person. The reporting persons filed jointly but disclaim group membership and beneficial ownership except to the extent of pecuniary interest.

Context
This was an institutional/affiliate purchase by a 10% owner rather than an executive officer. Such purchases can reflect increased stake by a significant shareholder, but the filing itself provides no explanation or strategy — avoid inferring motive.